Introduction to manufacturing concepts for individualized therapies - Where are we in Pharma?
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: FOLESTAD, Staffan (AstraZeneca, Pharmaceutical Technology & Development, Mölndal, Sweden)
- Co-author(s): Staffan Folestad: Pharmaceutical Technology & Development, AstraZeneca, Mölndal, Sweden
Advances in health outcomes the last 50 years were enabled by breakthrough medicinal products. Still, unmet medical needs remain and it has been emphasized that patient-centric healthcare, including personalized and precision medicine will constitute the basis for the next major wave of improvements in health outcomes. However, societal benefits.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.